Cryptosporidium: Host-Parasite Interactions and Pathogenesis

DJ Pinto, S Vinayak - Current Clinical Microbiology Reports, 2021 - Springer
Abstract Purpose of Review Cryptosporidium spp.(C. hominis and C. parvum) are a major
cause of diarrhea-associated morbidity and mortality in young children globally. While C …

An update on Cryptosporidium biology and therapeutic avenues

AK Dhal, C Panda, SIL Yun, RK Mahapatra - Journal of Parasitic Diseases, 2022 - Springer
Cryptosporidium species has been identified as an important pediatric diarrheal pathogen in
resource-limited countries, particularly in very young children (0–24 months). However, the …

Cryptosporidium PI(4)K inhibitor EDI048 is a gut-restricted parasiticidal agent to treat paediatric enteric cryptosporidiosis

UH Manjunatha, SB Lakshminarayana, RS Jumani… - Nature …, 2024 - nature.com
Diarrhoeal disease caused by Cryptosporidium is a major cause of morbidity and mortality in
young and malnourished children from low-and middle-income countries, with no vaccine or …

Safe and effective treatments are needed for cryptosporidiosis, a truly neglected tropical disease

IH Gilbert, S Vinayak, B Striepen, UH Manjunatha… - BMJ Global …, 2023 - gh.bmj.com
Early childhood cryptosporidiosis causes acute disease and mortality, as well as lasting
malnutrition and developmental delay. However, there are no safe and effective therapeutics …

[HTML][HTML] Microbiota-produced indole metabolites disrupt mitochondrial function and inhibit Cryptosporidium parvum growth

LJ Funkhouser-Jones, R Xu, G Wilke, Y Fu… - Cell reports, 2023 - cell.com
Cryptosporidiosis is a leading cause of life-threatening diarrhea in young children in
resource-poor settings. To explore microbial influences on susceptibility, we screened 85 …

Cryptosporidium uses CSpV1 to activate host type I interferon and attenuate antiparasitic defenses

S Deng, W He, AY Gong, M Li, Y Wang, Z **a… - Nature …, 2023 - nature.com
Cryptosporidium infects gastrointestinal epithelium and is a leading cause of infectious
diarrhea and diarrheal-related death in children worldwide. There are no vaccines and no …

Exploration of aminoacyl-tRNA synthetases from eukaryotic parasites for drug development

J Gill, A Sharma - Journal of Biological Chemistry, 2023 - jbc.org
Parasitic diseases result in considerable human morbidity and mortality. The continuous
emergence and spread of new drug-resistant parasite strains is an obstacle to controlling …

Emerging treatment options for cryptosporidiosis

MS Love, RKM Choy - Current opinion in infectious diseases, 2021 - journals.lww.com
Several lead compounds with potent activity in animal models and a favorable safety profile
have been identified. A sustained effort will be required to advance at least one to clinical …

Research progress on phosphatidylinositol 4-kinase inhibitors

G Li, Y Wu, Y Zhang, H Wang, M Li, D He… - Biochemical …, 2024 - Elsevier
Abstract Phosphatidylinositol 4-kinases (PI4Ks) could phosphorylate phosphatidylinositol
(PI) to produce phosphatidylinositol 4-phosphate (PI4P) and maintain its metabolic balance …

[HTML][HTML] Treating cryptosporidiosis: A review on drug discovery strategies.

AC Lenière, A Vlandas, J Follet - … Journal for Parasitology: Drugs and Drug …, 2024 - Elsevier
Despite several decades of research on therapeutics, cryptosporidiosis remains a major
concern for human and animal health. Even though this field of research to assess …